Bioeasun(Guangzhou Yixin Biotechnology Co., Ltd. )was established in 2014 and is located in Guangzhou High-tech Industrial Development Zone. It is a comprehensive biotechnology company that uses bio-nano-related technologies and raw materials as carriers and integrates the research, production and sales of nano-diagnostic reagents. The company has successively won the titles of "Guangdong Province's Specialized and Special New Enterprises", "Guangdong Province's High-tech Enterprises", "Guangzhou's Specialized and Special New Enterprises", "Guang zhou City's Specialized and Special New Enterprises " "Infectious Disease Diagnostic Reagents Industry Technology Innovation Alliance" enterprise, "Huangpu District Gazelle (Cultivation) Enterprise", "Guangzhou Huangpu District Science and Technology Bureau Nanotechnology Enterprise" et,al.Easunbio's core technology platform is divided into industrial technology platform and strategic technology platform. Among them, the industrialized technology platform covers a total area of 3,000 square meters, including a nanomagnetic bead platform, a molecular diagnostic platform,and a biological raw material platform. Bioeasun's 100,000-level clean factories have a total area of 2,000 square meters. It can meet the production needs of IVD diagnostic reagents and nanomagnetic beads. The daily production capacity is 1 million reaction nucleic acid extraction and purification reagents and 100 liters of nanomagnetic beads. It has complete advanced equipment and clean workshops required for the development and production of diagnostic products. The company's main products include functionalized nanomagnetic beads, sample pretreatment reagents and nucleic acid detection reagents.

Bioeasun's R&D team has a reasonable talent structure with professional backgrounds covering clinical medicine, biochemistry and molecular biology, genetics, organic chemistry, biotechnology, etc. Through years of independent research and development and continuous investment in R&D, Bioeasun has obtained and mastered a number of patented technologies, and relied on the above technologies to complete the R&D and industrialization of a series of in vitro diagnostic products, covering nano magnetic beads, nucleic acids extraction, pathogen detection and other application fields. The company has a complete process platform for monodispersed magnetic nanoparticles; it has developed monodispersed silicon-based, carboxyl-based and amino-based magnetic nanoparticles, and industrialized its application in extraction reagents for viruses, bacteria, free DNA and nucleic acids; based on immunodiagnostic reagents R&D platform, developed carboxyl and SA chemiluminescence immunoassay magnetic beads, and developed chemiluminescence immunoassay reagents on this basis; based on the cell nanomedicine R&D platform, developed small molecule therapeutic drugs for chronic myelogenous leukemia and cell therapy core raw material - immunomagnetic beads. A series of core technologies have been formed on each technology platform, which has strong market competitiveness.